VivoSeq
Other

Fractures

0

Pipeline Programs

5

Active Trials

5

Companies Involved

Fractures is an early-stage landscape with 0 programs across 5 companies. The most active players are Pfizer, GSK, Amgen.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

22/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

24/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

25

clinical trials

Completed12 · 48%
Terminated5 · 20%
Recruiting4 · 16%
Unknown status2 · 8%
Withdrawn1 · 4%
Not yet recruiting1 · 4%

Trial Activity

25 trials

Pain Alleviation of Forearm Fractures
Completed··N/A·NCT03377907·66 enrolled
Efficacy of DBM on Fractures of the Shinbone (Tibia)
Completed·EEmory University·Phase 4·NCT00299052·16 enrolled
Pain Palliation in Forearm Fractures in the Emergency Department
Completed··N/A·NCT06588907·85 enrolled
A Study of rhBMP-2/CPM in Closed Fractures of the Humerus
Completed·Pfizer logoPfizer·Phase 2·NCT00384852·139 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)